drugset / Trial / NCT06784570
Impact of Perioperative Levosimendan on Patients Undergoing Cardiac Surgery With Low Ejection Fraction
Non-randomizedParallel-groupOpen-labelPrevention
Summary
to compar levosemindan to other cardiac intropic medications that strengthen the heart in diffrent common adult heart surgery with patients with low ejection fraction(weak heart)
Timeline
- Start
- 2021-01-01
- Primary completion
- 2024-03-01
- Completion
- 2024-08-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Dopamine | Small molecule | — | — |
| Comparator | Epinephrine | Other / unclassified | — | — |
| Comparator | doputamine | Unknown | — | — |
| Subject | levosemindan | Unknown | 0.2 ug/kg | — |
| Comparator | noreadrenaline | Unknown | — | — |